Literature DB >> 27995724

Canagliflozin versus placebo for post-bariatric surgery patients with persistent type II diabetes: A randomized controlled trial (CARAT).

Karim Kheniser1, Sangeeta R Kashyap1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27995724     DOI： 10.1111/dom.12860

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  2 in total

Review 1.  Management of Diabetes in Patients Undergoing Bariatric Surgery.

Authors:  Christopher M Mulla; Harris M Baloch; Samar Hafida
Journal:  Curr Diab Rep       Date:  2019-11-04       Impact factor: 4.810

2.  Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study.

Authors:  Sangeeta R Kashyap; Karim Kheniser; Ali Aminian; Philip Schauer; Carel Le Roux; Bartolome Burguera
Journal:  Obes Sci Pract       Date:  2020-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.